Study of assessment of homoeopathic medicines to evaluate the eosinophil count in patients of allergic rhinitis.

Phase 3

• Conditions: Health Condition 1: J308- Other allergic rhinitis

• Registration Number: CTRI/2021/08/035616
• Lead Sponsor: I

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Cases of male and female will be included

2. Cases of 6 years to 45 years will be included

3. Patient who are fulfilling the criteria of allergic condition

4. Patient who are not on threatening condition

5. Patient with acute state of allergic rhinitis

6. Homoeopathic medicines which are prepared by some certified

pharmacy department

7. Medicines which are potantised with our own with the help

homoeopathic pharmacopoeia.

8. Childrens and adolescent patients are the main aspects to see the

effect of dose in the treatment of allergic rhinitis.

9. Patients with safe oesionphilic count

Exclusion Criteria

1. Homoeopathic medicines which are not prepared from standard

GMP Certified Homoeopathic Medicine Manufacturer

2. Patients who are not fulfilling the criteria of the disease

3. Patient with life threatening conditions like heart

attacks,accidental head injury

4. Patients on concomitant treatment/medication like hypertension

and diabetes

5. Patient who are not following the advises during the period of

treatment.

6. Patients with dangered level of oesinophilic count

Study & Design

• Study Type: Interventional
• Study Design: Not specified